Analysis of 17 neurotransmitters, metabolites and precursors in zebrafish through the life cycle using ultrahigh performance liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1001, Issue , 2015, Pages 191-201

  Santos Fandila, A ^a,b   Vazquez E ^a   Barranco, A ^a   Zafra Gomez A ^b   Navalon A ^b   Rueda, R ^a   Ramirez M ^a  

^a ABBOTT LABORATORIES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Analytical method validation; Life cycle; Neurotransmitters; UHPLC MS MS; Zebrafish

Indexed keywords

AMINO ACIDS; CHROMATOGRAPHY; CURRICULA; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; LIFE CYCLE; MASS SPECTROMETRY; METABOLITES; NEUROPHYSIOLOGY; NOREPINEPHRINE; SPECTROMETRY;

ANALYTICAL METHOD VALIDATION; ELECTROSPRAY IONIZATION INTERFACE; FOOD AND DRUGS ADMINISTRATIONS; NEUROTRANSMITTERS; TRIPLE-QUADRUPOLE MASS SPECTROMETER; U-HPLC-MS; ULTRAHIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRIES; ZEBRAFISH;

LIQUID CHROMATOGRAPHY;

4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; ACETYLCHOLINE; ADRENALIN; AGMATINE; BETAINE; CHOLINE; CITICOLINE; DOPAMINE; FORMIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; NEUROTRANSMITTER; NORADRENALIN; PHOSPHORYLCHOLINE; SEROTONIN; TRYPTOPHAN; TYROSINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEVELOPMENT; ELECTROSPRAY; EMBRYO; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIFE CYCLE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUADRUPOLE MASS SPECTROMETRY; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ZEBRA FISH; ANIMAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIFE CYCLE STAGE; METABOLISM; PROCEDURES;

DANIO RERIO;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIFE CYCLE STAGES; NEUROTRANSMITTER AGENTS; TANDEM MASS SPECTROMETRY; ZEBRAFISH;

EID: 84939492154     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.07.040     Document Type: Article

References (46)

1. Streisinger G., Walker C., Dower N., Knauber D., Singer F. Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 1981, 291:293-296.
2. Dooley K., Zon L.I. Zebrafish: a model system for the study of human disease. Curr. Opin. Genet. Dev. 2000, 10:252-256.
3. Barbazuk W.B., Korf I., Kadavi C., Heyen J., Tate S., Wun E., Bedell J.A., McPherson J.D., Johnson S.L. The syntenic relationship of the zebrafish and human genomes. Genome Res. 2000, 10:1351-1358.
4. Rico E.P., Rosemberg D.B., Seibt K.J., Capiotti K.M., Da Silva R.S., Bonan C.D. Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicol. Teratol. 2011, 33:608-617.
5. Rico E.P., Rosemberg D.B., Langoni Ada S., Souto A.A., Dias R.D., Bogo M.R., Bonan C.D., Souza D.O. Chronic ethanol treatment alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in zebrafish brain. Neurotoxicology 2011, 32:871-878.
6. Kalueff A.V., Stewart A.M., Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 2014, 35:63-75.
7. Suls A., Jaehn J.A., Kecskes A., Weber Y., Weckhuysen S., Craiu D.C., Siekierska A., Djemie T., Afrikanova T., Gormley P., von Spiczak S., Kluger G., Iliescu C.M., Talvik T., Talvik I., Meral C., Caglayan H.S., Giraldez B.G., Serratosa J., Lemke J.R., Hoffman-Zacharska D., Szczepanik E., Barisic N., Komarek V., Hjalgrim H., Moller R.S., Linnankivi T., Dimova P., Striano P., Zara F., Marini C., Guerrini R., Depienne C., Baulac S., Kuhlenbaumer G., Crawford A.D., Lehesjoki A.E., de Witte P.A., Palotie A., Lerche H., Esguerra C.V., De Jonghe P., Helbig I. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am. J. Hum. Genet. 2013, 93:967-975.
8. Stewart A.M., Kalueff A.V. The developing utility of zebrafish models for cognitive enhancers research. Curr. Neuropharmacol. 2012, 10:263-271.
9. Stewart A.M., Cachat J., Green J., Gaikwad S., Kyzar E., Roth A., Davis A., Collins C., El-Ounsi M., Pham M., Kalueff A.V. Constructing the habituome for phenotype-driven zebrafish research. Behav. Brain Res. 2013, 236:110-117.
10. Nery L.R., Eltz N.S., Hackman C., Fonseca R., Altenhofen S., Guerra H.N., Freitas V.M., Bonan C.D., Vianna M.R. Brain intraventricular injection of amyloid-beta in zebrafish embryo impairs cognition and increases tau phosphorylation effects reversed by lithium. PLOS ONE 2014, 9:e105862.
11. de Vrieze E., van de Wiel S.M., Zethof J., Flik G., Klaren P.H., Arjona F.J. Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish. Endocrinology 2014, 155:2320-2330.
12. Braida D., Ponzoni L., Martucci R., Sala M. A new model to study visual attention in zebrafish. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 55:80-86.
13. Ruhl T., Prinz N., Oellers N., Seidel N.I., Jonas A., Albayram O., Bilkei-Gorzo A., von der Emde G. Acute administration of THC impairs spatial but not associative memory function in zebrafish. Psychopharmacology (Berlin) 2014, 231:3829-3842.
14. Filippi A., Mueller T., Driever W. vglut2 and gad expression reveal distinct patterns of dual GABAergic versus glutamatergic cotransmitter phenotypes of dopaminergic and noradrenergic neurons in the zebrafish brain. J. Comp. Neurol. 2014, 522:2019-2037.
15. Braida D., Ponzoni L., Martucci R., Sparatore F., Gotti C., Sala M. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. Psychopharmacology (Berlin) 2014, 231:1975-1985.
16. Nishimura Y., Murakami S., Ashikawa Y. Zebrafish as a systems toxicology model for developmental neurotoxicity testing. Congenit. Anom. (Kyoto) 2015, 55:1-16.
17. Lee J., Freeman J.L. Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: a mini-review. Neurotoxicology 2014, 43:57-64.
18. Bernardi M.M., Dias S.G., Barbosa V.E. Neurotoxicity of neem commercial formulation (Azadirachta indica A. Juss) in adult zebrafish (Danio rerio). Environ. Toxicol. Pharmacol. 2013, 36:1276-1282.
19. Garcia-Cambero J.P., Catala M., Valcarcel Y. River waters induced neurotoxicity in an embryo-larval zebrafish model. Ecotoxicol. Environ. Saf. 2012, 84:84-91.
20. ISO 15088 Water Quality - Determination of the Acute Toxicity of Waste Water to Zebrafish Eggs (Danio rerio) 2007.
21. Lebold K.M., Kirkwood J.S., Taylor A.W., Choi J., Barton C.L., Miller G.W., Du J.L., Jump D.B., Stevens J.F., Tanguay R.L., Traber M.G. Novel liquid chromatography-mass spectrometry method shows that vitamin E deficiency depletes arachidonic and docosahexaenoic acids in zebrafish (Danio rerio) embryos. Redox Biol. 2014, 2:105-113.
22. Lebold K.M., Jump D.B., Miller G.W., Wright C.L., Labut E.M., Barton C.L., Tanguay R.L., Traber M.G. Vitamin E deficiency decreases long-chain PUFA in zebrafish (Danio rerio). J. Nutr. 2011, 141:2113-2118.
23. Sierra S., Alfaro J.M., Sanchez S., Burgos J.S. Administration of docosahexaenoic acid before birth and until aging decreases kainate-induced seizures in adult zebrafish. Brain Res. Bull. 2012, 88:467-470.
24. Newman M., Ebrahimie E., Lardelli M. Using the zebrafish model for Alzheimer's disease research. Front. Genet. 2014, 5:189.
25. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci. Biobehav. Rev. 2003, 27:3-18.
26. Kato T.A., Yamauchi Y., Horikawa H., Monji A., Mizoguchi Y., Seki Y., Hayakawa K., Utsumi H., Kanba S. Neurotransmitters psychotropic drugs and microglia: clinical implications for psychiatry. Curr. Med. Chem. 2013, 20:331-344.
27. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66:137-147.
28. Francis P.T. The interplay of neurotransmitters in Alzheimer's disease. CNS Spectr. 2005, 10:6-9.
29. Santana S., Rico E.P., Burgos J.S. Can zebrafish be used as animal model to study Alzheimer's disease?. Am. J. Neurodegener. Dis. 2012, 1:32-48.
30. Perry M., Li Q., Kennedy R.T. Review of recent advances in analytical techniques for the determination of neurotransmitters. Anal. Chim. Acta 2009, 653:1-22.
31. Moretti M., Matheus F.C., de Oliveira P.A., Neis V.B., Ben J., Walz R., Rodrigues A.L., Prediger R.D. Role of agmatine in neurodegenerative diseases and epilepsy. Front. Biosci. 2014, 6:341-359.
32. Analytical Methods Committee Is my calibration linear?. Analyst 1994, 119:2363-2366.
33. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine Guidance for Industry: Bioanalytical Method Validation 2001.
34. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
35. Su F., Wang F., Zhu R., Li H. Determination of 5-hydroxytryptamine norepinephrine dopamine and their metabolites in rat brain tissue by LC-ESI-MS-MS. Chromatographia 2009, 69:207-213.
36. Savci V., Wurtman R.J. Effect of cytidine on membrane phospholipid synthesis in rat striatal slices. J. Neurochem. 1995, 64:378-384.
37. Aricioglu-Kartal F., Regunathan S. Effect of chronic morphine treatment on the biosynthesis of agmatine in rat brain and other tissues. Life Sci. 2002, 71:1695-1701.
38. Cirillo C., Vanden Berghe P., Tack J. Role of serotonin in gastrointestinal physiology and pathology. Minerva Endocrinol. 2011, 36:311-324.
39. Panula P., Chen Y.C., Priyadarshini M., Kudo H., Semenova S., Sundvik M., Sallinen V. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol. Dis. 2010, 40:46-57.
40. Hultborn H., Nielsen J.B. Spinal control of locomotion - from cat to man. Acta Physiol. (Oxf.) 2007, 189:111-121.
41. Regunathan S. Agmatine: biological role and therapeutic potentials in morphine analgesia and dependence. AAPS J. 2006, 8:E479-E484.
42. Bruni G., Lakhani P., Kokel D. Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish. Front. Pharmacol. 2014, 5:153.
43. Kokel D., Bryan J., Laggner C., White R., Cheung C.Y., Mateus R., Healey D., Kim S., Werdich A.A., Haggarty S.J., Macrae C.A., Shoichet B., Peterson R.T. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 2010, 6:231-237.
44. Newman M., Verdile G., Martins R.N., Lardelli M. Zebrafish as a tool in Alzheimer's disease research. Biochim. Biophys. Acta 2011, 1812:346-352.
45. Newman M., Ebrahimie E., Lardelli M. Using the zebrafish model for Alzheimer's disease research. Front. Genet. 2014, 5:189.
46. Lee J., Freeman J.L. Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: a mini-review. Neurotoxicology 2014, 43:57-64.